Clinical trial
A Multiarm, Open-label, Multicenter, Phase 1b/2 Study to Evaluate Novel Combination Therapies in Subjects With Previously Treated Advanced EGFRm NSCLC
NCT03381274 is registered in ClinicalTrials.gov with MedImmune LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multiarm, Open-label, Multicenter, Phase 1b/2 Study to Evaluate Novel Combination Therapies in Subjects With Previously Treated Advanced EGFRm NSCLC
- Lead sponsor
- MedImmune LLC
- Phase
- Phase 1/2
- Overall status
- Active, not recruiting
- Start date
- May 8, 2018
- Completion date
- November 6, 2026
- Enrollment
- 43 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.